James L. Rogers

Array ( [id] => 13106835 [patent_doc_number] => 10072050 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-11 [patent_title] => Caustic stable chromatography ligands [patent_app_type] => utility [patent_app_number] => 12/653888 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 10 [patent_no_of_words] => 12870 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12653888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11575761 [patent_doc_number] => 09631008 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-25 [patent_title] => 'Immunoglobulin purification' [patent_app_type] => utility [patent_app_number] => 13/141306 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 7 [patent_no_of_words] => 5960 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13141306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487459 [patent_doc_number] => 20110236391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'METHOD FOR OBTAINING AN EXCIPIENT-FREE ANTIBODY SOLUTION' [patent_app_type] => utility [patent_app_number] => 13/132809 [patent_app_country] => US [patent_app_date] => 2009-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4860 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236391.pdf [firstpage_image] =>[orig_patent_app_number] => 13132809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8158454 [patent_doc_number] => 20120100148 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-04-26 [patent_title] => 'ANTI-FERROPORTIN 1 MONOCLONAL ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/628263 [patent_app_country] => US [patent_app_date] => 2009-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 28592 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0100/20120100148.pdf [firstpage_image] =>[orig_patent_app_number] => 12628263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8158454 [patent_doc_number] => 20120100148 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-04-26 [patent_title] => 'ANTI-FERROPORTIN 1 MONOCLONAL ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/628263 [patent_app_country] => US [patent_app_date] => 2009-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 28592 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0100/20120100148.pdf [firstpage_image] =>[orig_patent_app_number] => 12628263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11218847 [patent_doc_number] => 09447176 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-20 [patent_title] => 'Methods and compositions for treating complement-associated disorders' [patent_app_type] => utility [patent_app_number] => 13/128523 [patent_app_country] => US [patent_app_date] => 2009-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38806 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13128523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13209211 [patent_doc_number] => 10118962 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-06 [patent_title] => Methods for purification of single domain antigen binding molecules [patent_app_type] => utility [patent_app_number] => 12/608964 [patent_app_country] => US [patent_app_date] => 2009-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 21923 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 185 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12608964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6164921 [patent_doc_number] => 20110195079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'IMMUNIZATION PROTOCOL FOR DIRECTED EXPANSION AND MATURATION' [patent_app_type] => utility [patent_app_number] => 13/125526 [patent_app_country] => US [patent_app_date] => 2009-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3918 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195079.pdf [firstpage_image] =>[orig_patent_app_number] => 13125526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6245704 [patent_doc_number] => 20100136025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'VIRAL INACTIVATION DURING PURIFICATION OF ANTIBODIES CROSS REFERENCE TO RELATED APPLICATIONS' [patent_app_type] => utility [patent_app_number] => 12/582556 [patent_app_country] => US [patent_app_date] => 2009-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 34407 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20100136025.pdf [firstpage_image] =>[orig_patent_app_number] => 12582556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6031899 [patent_doc_number] => 20110081642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'Selection of B Cells with Specificity of Interest: Method of Preparation and Use' [patent_app_type] => utility [patent_app_number] => 12/573617 [patent_app_country] => US [patent_app_date] => 2009-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 31724 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20110081642.pdf [firstpage_image] =>[orig_patent_app_number] => 12573617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11218842 [patent_doc_number] => 09447171 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-20 [patent_title] => 'Purification process for fragment antibodies' [patent_app_type] => utility [patent_app_number] => 13/122676 [patent_app_country] => US [patent_app_date] => 2009-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4661 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13122676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6091063 [patent_doc_number] => 20110218327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'METHOD FOR PROVIDING A β-LACTOGLOBULIN PRODUCT AND AN a-ENRICHED WHEY PROTEIN ISOLATE' [patent_app_type] => utility [patent_app_number] => 13/063579 [patent_app_country] => US [patent_app_date] => 2009-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17583 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20110218327.pdf [firstpage_image] =>[orig_patent_app_number] => 13063579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9827818 [patent_doc_number] => 08937046 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-20 [patent_title] => 'Modulating the alternative complement pathway' [patent_app_type] => utility [patent_app_number] => 13/120125 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 21 [patent_no_of_words] => 37376 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13120125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8571929 [patent_doc_number] => 08338577 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-25 [patent_title] => 'Methods for quantifying protein leakage from protein based affinity chromatography resins' [patent_app_type] => utility [patent_app_number] => 12/584931 [patent_app_country] => US [patent_app_date] => 2009-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7320 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12584931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6302351 [patent_doc_number] => 20100068210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE PREVENTION OF OXIDATIVE DEGRADATION OF PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/556388 [patent_app_country] => US [patent_app_date] => 2009-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 14490 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20100068210.pdf [firstpage_image] =>[orig_patent_app_number] => 12556388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6102839 [patent_doc_number] => 20110166332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'ENHANCED ANTIBODY AGGREGATE REMOVAL WITH CAPTO ADHERE IN THE PRESENCE OF PROTEIN-EXCLUDED ZWITTERIONS' [patent_app_type] => utility [patent_app_number] => 13/063221 [patent_app_country] => US [patent_app_date] => 2009-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4263 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166332.pdf [firstpage_image] =>[orig_patent_app_number] => 13063221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7509968 [patent_doc_number] => 20110256136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'Complement Inhibitors For Treatment Of Injury From Intracerebral Hemorrhage' [patent_app_type] => utility [patent_app_number] => 13/059482 [patent_app_country] => US [patent_app_date] => 2009-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10623 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256136.pdf [firstpage_image] =>[orig_patent_app_number] => 13059482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6084801 [patent_doc_number] => 20110144311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'METHODS FOR PURIFYING ANTIBODIES USING PROTEIN A AFFINITY CHROMATOGRAPHY' [patent_app_type] => utility [patent_app_number] => 13/058301 [patent_app_country] => US [patent_app_date] => 2009-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 13126 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20110144311.pdf [firstpage_image] =>[orig_patent_app_number] => 13058301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5969228 [patent_doc_number] => 20110150960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'HAZARDOUS SUBSTANCE REMOVING MATERIAL AND METHOD FOR REMOVING HAZARDOUS SUBSTANCE' [patent_app_type] => utility [patent_app_number] => 12/737611 [patent_app_country] => US [patent_app_date] => 2009-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8714 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20110150960.pdf [firstpage_image] =>[orig_patent_app_number] => 12737611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6528558 [patent_doc_number] => 20100015139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'METHOD OF INHIBITING COMPLEMENT ACTIVATION WITH FACTOR Ba SPECIFIC ANTIBODIES AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/501165 [patent_app_country] => US [patent_app_date] => 2009-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20491 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015139.pdf [firstpage_image] =>[orig_patent_app_number] => 12501165 [rel_patent_id] =>[rel_patent_doc_number] =>)